Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 900 participants.

Also called NCT06591390

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06591390
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06591390. Randomized; double masking; primary purpose treatment. Start 2022-02-09 (actual); primary completion 2024-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
Intervention (Drug)
Ticagrelor 90 MG
Intervention (Drug)
Cilostazol 100 MG
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06591390
Content hash
5352f7fc0e0dd490005cf6a41f3892741ba26fa8ecca4d4ef517f7b83a7b7e8b